Where does the money go?
In the last few years, Health Canada approved several new drugs for the treatment of myeloma, more than have been approved over the past ten years. Health Canada approval, however, is only the first step in the long process of securing provincial funding for public drug programs.
The Multiple Myeloma March helps to increase awareness and raise funds to drive clinical research and to support advocacy, for accelerated access to game-changing therapies for Canadian patients.
For more detailed information on where your money goes, download or view a copy of the latest Myeloma Canada Annual Report